Quantification and localisation of FOXP3+ T lymphocytes and relation to hepatic inflammation during chronic HCV infection

Journal of Hepatology

Volumn 47, Issue 3, 2007, Pages 316-324

  Ward, Scott M ^a   Fox, Bridget C ^b   Brown, Philip J ^b   Worthington, Joy ^c   Fox, Stephen B ^d   Chapman, Roger W ^c   Fleming, Kenneth A ^e   Banham, Alison H ^b   Klenerman, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Disease progression; FOXP3; Hepatitis C virus; Liver; Regulatory T cell

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADULT; ANALYTIC METHOD; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN CELL; LIVER BIOPSY; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; REGULATORY T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; BIOPSY; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HEPATITIS C, CHRONIC; HUMANS; LEUKOCYTE COUNT; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY;

EID: 34547604820     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2007.03.023     Document Type: Article

References (42)

1. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
2. Liang T.J., Rehermann B., Seeff L.B., and Hoofnagle J.H. Pathogenesis, natural history, treatment, and prevention of hepatitis C. Ann Intern Med 132 (2000) 296-305
3. Cerny A., and Chisari F.V. Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30 (1999) 595-601
4. Poynard T., Ratziu V., Charlotte F., Goodman Z., McHutchison J., and Albrecht J. Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C. J Hepatol 34 (2001) 730-739
5. Seeff L.B. The natural history of hepatitis C-A quandary. Hepatology 28 (1998) 1710-1712
6. Asanza C.G., Garcia-Monzon C., Clemente G., Salcedo M., Garcia-Buey L., Garcia-Iglesias C., et al. Immunohistochemical evidence of immunopathogenetic mechanisms in chronic hepatitis C recurrence after liver transplantation. Hepatology 26 (1997) 755-763
7. Kamal S.M., Graham C.S., He Q., Bianchi L., Tawil A.A., Rasenack J.W., et al. Kinetics of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses in HCV and Schistosoma mansoni coinfection: relation to progression of liver fibrosis. J Infect Dis 189 (2004) 1140-1150
8. Liaw Y.F., Lee C.S., Tsai S.L., Liaw B.W., Chen T.C., Sheen I.S., et al. T-cell-mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 22 (1995) 1368-1373
9. Moreno-Otero R., Garcia-Buey L., Mateos F.G., and Garcia-Monzon C. Pathogenesis of chronic viral hepatitis: lessons from immunohistochemistry. Viral Hepat Rev 2 (1996) 61-79
10. Gerlach J.T., Diepolder H.M., Jung M.C., Gruener N.H., Schraut W.W., Zachoval R., et al. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C. Gastroenterology 117 (1999) 933-941
11. He X.S., Rehermann B., Lopez-Labrador F.X., Boisvert J., Cheung R., Mumm J., et al. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc Natl Acad Sci U S A 96 (1999) 5692-5697
12. Kamal S.M., Rasenack J.W., Bianchi L., Al Tawil A., El Sayed Khalifa K., Peter T., et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response. Gastroenterology 121 (2001) 646-656
13. Barnes E., Harcourt G., Brown D., Lucas M., Phillips R., Dusheiko G., et al. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36 (2002) 743-754
14. Day C.L., Seth N.P., Lucas M., Appel H., Gauthier L., Lauer G.M., et al. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J Clin Invest 112 (2003) 831-842
15. Lauer G.M., Ouchi K., Chung R.T., Nguyen T.N., Day C.L., Purkis D.R., et al. Comprehensive analysis of CD8(+)-T-cell responses against hepatitis C virus reveals multiple unpredicted specificities. J Virol 76 (2002) 6104-6113
16. Rehermann B., Chang K.M., McHutchison J.G., Kokka R., Houghton M., and Chisari F.V. Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection. J Clin Invest 98 (1996) 1432-1440
17. Grabowska A.M., Lechner F., Klenerman P., Tighe P.J., Ryder S., Ball J.K., et al. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur J Immunol 31 (2001) 2388-2394
18. Spangenberg H.C., Viazov S., Kersting N., Neumann-Haefelin C., McKinney D., Roggendorf M., et al. Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection. Hepatology 42 (2005) 828-837
19. Boettler T., Spangenberg H.C., Neumann-Haefelin C., Panther E., Urbani S., Ferrari C., et al. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection. J Virol 79 (2005) 7860-7867
20. Cabrera R., Tu Z., Xu Y., Firpi R.J., Rosen H.R., Liu C., et al. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40 (2004) 1062-1071
21. Rushbrook S.M., Ward S.M., Unitt E., Vowler S.L., Lucas M., Klenerman P., et al. Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection. J Virol 79 (2005) 7852-7859
22. Sugimoto K., Kaplan D.E., Ikeda F., Ding J., Schwartz J., Nunes F.A., et al. Strain-specific T-cell suppression and protective immunity in patients with chronic hepatitis C virus infection. J Virol 79 (2005) 6976-6983
23. Accapezzato D., Francavilla V., Paroli M., Casciaro M., Chircu L.V., Cividini A., et al. Hepatic expansion of a virus-specific regulatory CD8(+) T cell population in chronic hepatitis C virus infection. J Clin Invest 113 (2004) 963-972
24. Baecher-Allan C., Brown J.A., Freeman G.J., and Hafler D.A. CD4+CD25high regulatory cells in human peripheral blood. J Immunol 167 (2001) 1245-1253
25. Dieckmann D., Plottner H., Berchtold S., Berger T., and Schuler G. Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. J Exp Med 193 (2001) 1303-1310
26. Jonuleit H., Schmitt E., Stassen M., Tuettenberg A., Knop J., and Enk A.H. Identification and functional characterization of human CD4(+)CD25(+) T cells with regulatory properties isolated from peripheral blood. J Exp Med 193 (2001) 1285-1294
27. Levings M.K., Sangregorio R., and Roncarolo M.G. Human cd25(+)cd4(+) t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 193 (2001) 1295-1302
28. Walker M.R., Kasprowicz D.J., Gersuk V.H., Benard A., Van Landeghen M., Buckner J.H., et al. Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest 112 (2003) 1437-1443
29. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 103 (2006) 6659-6664
30. Walker M.R., Carson B.D., Nepom G.T., Ziegler S.F., and Buckner J.H. De novo generation of antigen-specific CD4+CD25+ regulatory T cells from human CD4+CD25- cells. Proc Natl Acad Sci U S A 102 (2005) 4103-4108
31. Gruener N.H., Lechner F., Jung M.C., Diepolder H., Gerlach T., Lauer G., et al. Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus. J Virol 75 (2001) 5550-5558
32. Lechner F., Gruener N.H., Urbani S., Uggeri J., Santantonio T., Kammer A.R., et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur J Immunol 30 (2000) 2479-2487
33. Roncador G., Brown P.J., Maestre L., Hue S., Martinez-Torrecuadrada J.L., Ling K.L., et al. Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35 (2005) 1681-1691
34. Bachem M.G., Riess U., Melchior R., Sell K.M., and Gressner A.M. Transforming growth factors (TGF alpha and TGF beta 1) stimulate chondroitin sulfate and hyaluronate synthesis in cultured rat liver fat storing cells. FEBS Lett 257 (1989) 134-137
35. Nakamura T., Sakata R., Ueno T., Sata M., and Ueno H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32 (2000) 247-255
36. Olaso E., and Friedman S.L. Molecular regulation of hepatic fibrogenesis. J Hepatol 29 (1998) 836-847
37. Ishak K., Baptista A., Bianchi L., Callea F., De Groote J., Gudat F., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 (1995) 696-699
38. Longhi M.S., Hussain M.J., Mitry R.R., Arora S.K., Mieli-Vergani G., Vergani D., et al. Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis. J Immunol 176 (2006) 4484-4491
39. Lan R.Y., Cheng C., Lian Z.X., Tsuneyama K., Yang G.X., Moritoki Y., et al. Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43 (2006) 729-737
40. Lee J.H., Wang L.C., Lin Y.T., Yang Y.H., Lin D.T., and Chiang B.L. Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology 117 (2006) 280-286
41. Morgan M.E., van Bilsen J.H., Bakker A.M., Heemskerk B., Schilham M.W., Hartgers F.C., et al. Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Human Immunol 66 (2005) 13-20
42. Karagiannidis C., Akdis M., Holopainen P., Woolley N.J., Hense G., Ruckert B., et al. Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. J Allergy Clin Immunol 114 (2004) 1425-1433